Novo Nordisk
NVO
NVO
1,047 hedge funds and large institutions have $19.3B invested in Novo Nordisk in 2022 Q4 according to their latest regulatory filings, with 206 funds opening new positions, 296 increasing their positions, 352 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
16% more funds holding
Funds holding: 905 → 1,047 (+142)
0.51% more ownership
Funds ownership: 15.94% → 16.45% (+0.51%)
16% less repeat investments, than reductions
Existing positions increased: 296 | Existing positions reduced: 352
Holders
1,047
Holding in Top 10
46
Calls
$252M
Puts
$142M
Top Buyers
| 1 | +$412M | |
| 2 | +$173M | |
| 3 | +$131M | |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$81M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$78.6M |
Top Sellers
| 1 | -$317M | |
| 2 | -$71.8M | |
| 3 | -$65.5M | |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$46.5M |
| 5 |
Fisher Asset Management
Camas,
Washington
|
-$36M |